Navigation Links
Cell Genesys Provides Final Median Survival Data From Second Phase,2 Trial of GVAX Immunotherapy for Prostate Cancer

SOUTH SAN FRANCISCO, Calif., April 03, 2007 /PRNewswire-FirstCall/ -- Cell Genesys, Inc. today announced final, updated results from its second multi-center Phase 2 trial of GVAX immunotherapy for prostate cancer which evaluated escalating doses of the immunotherapy in 80 patients with metastatic hormone-refractory prostate cancer (HRPC). Additional follow-up of the 22 patients who received the dose that is comparable to that being employed in the company's ongoing Phase 3 program indicates that the median survival is 35.0 months. Four patients have withdrawn consent to further follow-up and thus were censored in the analysis. The company previously reported final median survival results from its first multi-center Phase 2 trial of GVAX immunotherapy for prostate cancer in 34 patients with metastatic HRPC that showed an overall median survival of 26.2 months. The survival results from the two, independent multi-center Phase 2 clinical trials compare favorably to the previously published median survival of 18.9 months for metastatic hormone-refractory prostate cancer patients treated with Taxotere(R) (docetaxel) chemotherapy plus prednisone, the current standard of care for these patients. The company's ongoing Phase 3 program is designed to confirm this potential survival benefit for GVAX immunotherapy for prostate cancer.

"We are certainly encouraged by the survival data from the second Phase 2 trial of GVAX immunotherapy for prostate cancer. The final median survival of 35.0 months also compares favorably to a predicted median survival of 22.0 months for these 22 patients based on a validated, published nomogram using seven prognostic variables," stated Rob Dow, M.D., chief medical officer of Cell Genesys. "We continue to hope that GVAX immunotherapy for prostate cancer may some day offer a new treatment option for patients with this disease."

GVAX immunotherapy for prostate cancer is currently
'"/>




Page: 1 2 3

Related medicine technology :

1. Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer
2. Cell Genesys Reports GVAX Immunotherapy for Prostate Cancer Induces a Broad, Patient-Specific Antibody Response
3. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
4. XTL Provides Update on Phase I Clinical Trial of XTL-2125
5. Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides Sustained Immune Response in 100 Percent of Women up to 55 Years of Age
6. Daytrana (methylphenidate transdermal system) Provides Significant Effectiveness in ADHD Symptom Relief in Both Boys and Girls
7. DURECT Provides an Update to the Memryte Program Under Development by Voyager Pharmaceutical Corp
8. NicOx Provides an Update on the Phase 2a Study for NCX 1000 Conducted With Axcan
9. Indivumed Study Provides Sound Scientific Basis for a Predictive Drug Test- Platform
10. Rigel Provides Clinical Update of R788 Phase 2 Trials in ITP, Rheumatoid Arthritis and Lymphoma
11. New Analysis of Data from WHI Provides Reassurance With Respect to Coronary Heart Disease For Newly Menopausal Women Considering Hormone Therapy

Post Your Comments:
(Date:11/24/2009)...GH,Nov.24/PRNewswire/-- ,, WHAT:RomHoubens,aBel...nautoaccident,wasactuallyfullyconsciousandawakedur...gment.TheDynaVoxEyeMaxwasfeaturedinthesegmenttoill...tionscanunlockcommunication. ,, WHEN:GoodMornin... www.dynavoxtech.com ,, WHO:RomHoubenswasan...
(Date:11/24/2009)...Calif.,Nov.24/PRNewswire-FirstCall/--Vermillion,In...itsPlanofReorganizationandDisclosureStatementtoday...tfortheDistrictofDelaware.Ahearingtoconsiderapprov...ecember8,2009,withthehearingontheconfirmationofthe...ortheCompanytopayallclaimsinfull.ThePlanisexpected...
(Date:11/24/2009)...Md.,Nov.24/PRNewswire/--Inadditiontofamily,friends...delphiajurorstoherThanksgivinggratitudelist. ,,...fultothem,"shesaidofMonday,sverdictstotaling$103mi...isneskiisamong12,000womennationwidewhohavesuedWyet...ydrugsPremarinandPrempro.Wisneskiandtheothervictim...
Breaking Medicine Technology:DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Maryland Woman Thankful for Wyeth Verdicts 2Elsevier and Canadian College of Health Service Executives announce new publishing partnership 56589 1Elsevier and Canadian College of Health Service Executives announce new publishing partnership 56589 2Four fifths of businesses foresee problems maintaining operations if H1N1 flu outbreak 56586 1Four fifths of businesses foresee problems maintaining operations if H1N1 flu outbreak 56586 2Four fifths of businesses foresee problems maintaining operations if H1N1 flu outbreak 56586 3Four fifths of businesses foresee problems maintaining operations if H1N1 flu outbreak 56586 4U of I acientist 3A Public policy should promote family mealtimes 56583 1U of I acientist 3A Public policy should promote family mealtimes 56583 2U of I acientist 3A Public policy should promote family mealtimes 56583 3
... Bermuda, Dec. 23 Warner Chilcott Limited (Nasdaq...aries and Mayne Pharma International Pty. Ltd. ("M...lawsuits against each of Mutual Pharmaceutical Com...("Mylan") and Impax Laboratories, Inc. ("Impax") ...ey for infringement of Mayne,s U.S. Patent No. 6,9...
...lestone met in development and validation of non-a...ass., Dec. 17 MatTek Corporation today announced ...) endorsed the scientific validity of the Modified...r meeting. ESAC concluded that the Modified EpiDe... the prediction of skin irritating and non-irritat...
Other Medicine Technology:Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent 2Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent 3EpiDerm's Skin Irritation Test Fully Validated in European Union 2
(Date:11/26/2009)...al rollercoaster, study finds , , THURSD...actor meets the jubilant sports fan. , A new st...ho root for the winning team -- enjoy the greatest...d victory was in doubt, producing feelings of worr...iving weekend as you,re glued to the TV set, watch...
(Date:11/26/2009)..., P.A. is offering free nationwide confidential co...rol pills who have suffered a Deep Vein Thrombosis...r other related cardiac issues or had their Gallbl...56-6405 or go to the firm’s website at http...valuation form. , (PRWEB)...
(Date:11/25/2009)...leMedicalInc.,aleadingmanufacturerofbreastMRIcoils...wleadingedgeclinicalapplicationsonitsAegis(TM)medi...SocietyofNorthAmerica(RSNA)annualmeetinginChicago,...leveragetheuniquehighqualityimagesgeneratedbySenti...eimagingmodalitiesformulti-parametricassessment. ,...
(Date:11/25/2009)...s,andPressJoinEfforttoEducate ,, MEMPHIS,Tenn....nalBipolarFoundationandtheMedicAlertFoundationrece...ram,whichisnowbeingwidelyacceptedasapreventiveheal...ipolarFoundationreceivedaproclamationofendorsement...ouisianaMitchLandrieu.TheNationalBipolarFoundation...
(Date:11/25/2009)... draw definite conclusions, experts say, , ...abetic patients with blocked coronary arteries, th... year whether patients undergo bypass surgery or a...rt. , Bypass surgery has been the standard trea...isease. However, less invasive approaches such as ...
Breaking Medicine News(10 mins):Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3
...l journals and news media to increase the awarenes...tional funds// to increase child survival. The Lan...rojects are achievable, Millennium Development Goa...child welfare should be created from funding from ...
...een revealed that most of the gray wolf pups born ...The reason attributed to this catastrophe is a do...the 69 pups born last year are still alive. This w...eeks, he said, officials plan to catch Yellowstone...
...ng to Himachal Pradesh are committing suicide by c... lifestyles.// In the year 2005 alone, as many as ..., according to sources from the State Forensic Lab...J.R. Gaur, Director of the Himachal Pradesh Forens...
...have expressed the ‘high alert’ situation, followi... and hospital admission of several others// (26) b...ion, this situation has prompted fears of a human-...nical laboratory situated in England, had pointed ...
...was always profiled as a disease of the Neurons or... finger on the participation// of Astrocytes in re...tween Astrocytes and Alzheimer’s. According to...of Astrocytes (Star shaped cells) in triggering ce...
... the metastasis of the neuroblastoma. This researc...spital and the University of California// at San D...elf from the main primary tumor have lost the func...t in the nervous system. It is commonly seen in ch...
Other Medicine News:Health News:Europe On High Bird Flu Alert: European Commission 2Health News:Metastasis of Neuroblastoma linked to Loss Of Caspase-8 gene 2
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
Medicine Products: